How has COVID-19 affected breast cancer screening?
In this opinion piece from our sister site Oncology Central, find out about how COVID-19 has impacted breast cancer screening. Highlights include: reasons for the dramatic decrease in the screening of breast cancer and how breast cancer risk assessments can be made more efficient by collecting data from patients’ electronic health records.
Please introduce yourself, your research background and current research interests.
My name is Katherine Crew and I’m a breast medical oncologist at Columbia University Irving Medical Center in New York City (NY, USA). I also direct the Clinical Breast Cancer Prevention Program at the Herbert Irving Comprehensive Cancer Center. My research focuses on implementing breast cancer risk assessment into clinical practice and adopting risk-stratified approaches to breast cancer screening and prevention.
